购物车
全部删除
您的购物车当前为空
SOS1-IN-20 (Compound 12f) 是一种口服活性的SOS1抑制剂,对KRASG12C::SOS1的IC50为5.11 nM。它通过阻断KRAS与SOS1的相互作用来抑制KRAS的活化及其下游信号传导。在PC-9细胞中,SOS1-IN-20 对p-ERK的IC50为253 nM,对 hERG通道的IC50为16.71 μM。此化合物能抑制肿瘤细胞增殖,展现出抗肿瘤活性。
SOS1-IN-20 (Compound 12f) 是一种口服活性的SOS1抑制剂,对KRASG12C::SOS1的IC50为5.11 nM。它通过阻断KRAS与SOS1的相互作用来抑制KRAS的活化及其下游信号传导。在PC-9细胞中,SOS1-IN-20 对p-ERK的IC50为253 nM,对 hERG通道的IC50为16.71 μM。此化合物能抑制肿瘤细胞增殖,展现出抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SOS1-IN-20 相关产品
| 产品描述 | SOS1-IN-20 (Compound 12f) is an orally active inhibitor of SOS1, exhibiting an IC50 of 5.11 nM against KRASG12C::SOS1. It prevents KRAS activation and its downstream signaling by disrupting the KRAS-SOS1 interaction. In PC-9 cells, it shows an IC50 of 253 nM for p-ERK, while its IC50 for the hERG channel is 16.71 μM. SOS1-IN-20 also inhibits tumor cell proliferation, displaying antitumor activity. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容